Authors


Surabhi Dangi-Garimella, PhD

Latest:

ASCEND Trial: Aspirin Prevents Serious Vascular Events in Diabetes

Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ongoing ESC Congress in Munich, Germany.


Joe Maki, Senior Director, Pharmacy Business Operations, Novant Health

Latest:

Strategies for Successful IDN-based Specialty Pharmacy: The Financial Perspective

An in-house specialty pharmacy can provide significant financial gain for health systems by preventing revenue from being diverted to outside pharmacies.



Howard R. Underwood, MD, MBA, MS

Latest:

Incentive Formularies: Spending and Utilization for 3 Common Drug Classes

Incentive formularies with varying cost sharing led to modestly lower overall spending, with savings for plan sponsors offset by increased out-of-pocket spending.


Eileen Myers, MPH

Latest:

Prefilled Syringe Vaccine Doses: An Emerging Option in the Retail-Based Clinic Setting

Prefilled syringe use offers advantages that can help pharmacists improve quality of care.


Eugene Borukhovich

Latest:

The Impact of Precision Medicine and the 21st Century Cures Act on Modern Pharma

The United States accounts about 40% of the global pharmaceutical market.


Timothy R. Hudd, BS, PharmD, RPh, AE-C

Latest:

Managing Severe Asthma: Key Considerations When Recommending Therapy

Advancements in the understanding of asthma pathophysiology has led to the discovery of defined asthma phenotypes and targeted interventions involving novel biologic therapies.


By Kate H. Gamble, Senior Editor

Latest:

Support for Breastfeeding Moms Lacking, Says CDC

Despite the fact that breastfeeding leads to better overall health and fewer doctor visits and prescriptions, mothers aren't getting the support they need.



Robert J. Nordyke, PhD

Latest:

Synchronization of Treatment With Erythropoiesis-Stimulating Agents and Chemotherapy

In outpatient oncology clinics, erythropoiesis-stimulating agents and chemotherapy were found to be typically administered during the same visits, as opposed to requiring separate visits.


Ann McNamara, PharmD

Latest:

The Value of Integration in a Health System Specialty Pharmacy Hepatitis C Program

Integrated, coordinated care and access to the electronic medical record provide many unique opportunities to enhance overall care and decrease costs associated with hepatitis C therapy.


Gerald L. Klein, MD

Latest:

Pilot Pharmacoeconomic Analysis of Serum-derived Bovine Immunoglobulin Use in IBD

This pilot study analyzes the cost savings of utilizing a prescription medical food, serum-derived bovine immunoglobulin/protein isolate, for the management of inflammatory bowel disease in a small cohort.



Scot Walker, PharmD, MS, BCPS, BCACP

Latest:

Using Digital Media to Counsel Patients

Advancements in our ability to care for patients have enabled us to control and sometimes cure many diseases.





BY LOUIS FERRARI, MBA, RPH

Latest:

The Evolving Epilepsy Treatment Spectrum: A Review of Antiepileptic Drugs in Late Development

Given the relatively static rate of seizure freedom with the current antiepileptic drug (AED) armamentarium, a need remains for the development of new compounds to help enable more patients achieve seizure freedom. Fortunately, several investigational therapeutic agents and delivery systems are in phase 3 development, which are being investigated for the treatment of orphan diseases and focal-onset and generalized-onset seizures.



Rebecca L. Nelson, PharmD, RPh

Latest:

Medication Adherence: A Vital Portion of the Treatment Plan

Non-adherence to medications is one of the country's largest and most expensive disease categories. Specialty pharmacists play a vital role in improving adherence.



Lindsay Kaster, PharmD, BCOP

Latest:

Tech Duties Increase in Health Systems

Technicians pick up administrative tasks so pharmacists can spend more time on direct patient care.


Debra F. Eisenberg, PhD, MS

Latest:

Rehospitalizations and Direct Medical Costs for cSSSI: Linezolid Versus Vancomycin

Among commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.



Jeff Engle, PharmD, MS

Latest:

New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemia

Patients with CLL may have genetic mutations that predict response to different treatments.


Nicholas Rioux

Latest:

Interactive Case Studies (September 2020)

What would you recommend to these patients?


Jeremy Faulks, PharmD

Latest:

Driving Patient Adherence (and Outcomes) Through Appointment-Based Refill Programs

One of the biggest struggles facing patients today is ensuring they have the proper medications on hand and that they are taking their medications correctly.




Sharon M. Wang, PharmD, MS

Latest:

Recent Trends in the Treatment of Chronic Hepatitis C

This article is an early utilization review of newer, more effective, and more costly regimens for the treatment of hepatitis C.